Mandate

Vinge advises the Swedish state in connection with the recapitalization of SAS

Vinge advises the Swedish state in connection with the recapitalization of SAS. The recapitalization plan, which includes State aid that has been approved by the EU Commission, restores SAS’ equity by SEK 14.25 billion and secures approximately SEK 12 billion of new funding.

The recapitalization plan consists of a directed issue of shares to the Swedish and Danish states, a rights issue of shares to existing shareholders, two directed issues of hybrid notes, of which one is directed to the Swedish and Danish states and one is directed to the Danish state, as well as conversion of existing hybrid notes into shares and of existing bonds into new hybrid notes or shares. The conversion of debt instruments aims at distributing the economic burden of the company’s recapitalization. In aggregate, the Swedish state provides SAS with SEK 5 billion in connection with the recapitalization of the company.

Vinge’s team consisted of Charlotte Levin, Erik Sjöman, Martin Johansson, Amanda Knutsson, Hedvig Josefson and Julia Hirschberg.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025